Table 2.
C | SF (Calverley) | FB (Szafranski) | S (Calverley) | F (Calverley) | |
---|---|---|---|---|---|
Exacerbation RR (vs placebo) | 0.70 | 0.76 | 0.80 | 0.81 | |
Symptom-free days | 0% | 14% | 12% | 3% | 2% |
Abbreviations: C, control; F, fluticasone alone; FB, formoterol/budesonide; RR, relative risk; S, salmeterol alone; SF, salmeterol/fluticasone.